Germany - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient epoetin zeta (recombinant human erythropoietin)

This tender with title Germany - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient epoetin zeta (recombinant human erythropoietin) --
Abschluss nicht-exklusiver Arzneimittel-Rabattvereinbarungen nach § 130a Abs. 8 SGB V im Wege eines sog. Open-House-Modells zum Wirkstoff Epoetin zeta (rekombinantes humanes Erythropoetin) has been published on Bidding Source portal dated 29 Mar 2023 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.